← back to search

Lorenza Scotti

Piedmont University · IT
Area of research
Oncology · Infectious Diseases
Research interest
Research interests include COVID-19 and healthcare impacts, COVID-19 Clinical Research Studies, Alcohol Consumption and Health Effects, and Pharmacovigilance and Adverse Drug Reactions.
h-index
49
citations
8,211
works
182
NIH funding
primary concept
Medicine
email

Recent publications

Prevalence and incidence of pressure injury in adult patients receiving non-invasive ventilation for acute respiratory failure: a systematic review and meta-analysis protocol.
2026cited by 0position: contributordoi
Operational Definitions of Polypharmacy and Their Association with All-Cause Hospitalization Risk: A Conceptual Framework Using Administrative Databases.
2025cited by 2position: contributordoi
Victims of drug facilitated sexual assault aged 13-24: a cross sectional study on the pool of users of a sexual violence relief centre in Northern Italy.
2024cited by 4position: contributordoi
Study Design and Research Protocol for diagnostic or prognostic studies in the Age of Artificial Intelligence: A Biostatistician’s Perspective
Epidemiology Biostatistics and Public Health 2024cited by 1position: middledoi
Pain Treatment Beyond Spasticity: The Role of AbobotulinumtoxinA in the Rehabilitation of Multiple Sclerosis
Toxicon 2024cited by 0position: middledoi
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry
The Lancet Oncology 2023cited by 34position: middledoi
Clinical efficacy of botulinum toxin type A in patients with traumatic brain injury, spinal cord injury, or multiple sclerosis: An observational longitudinal study
Frontiers in Neurology 2023cited by 18position: middledoi
Comparative efficacy of novel combination strategies for unresectable hepatocellular carcinoma: A network metanalysis of phase III trials
European Journal of Cancer 2022cited by 57position: middledoi
Worse Disease Prognosis Is Associated to an Increase of Platelet-Derived Extracellular Vesicles in Hospitalized SARS-CoV-2 Patients.
2022cited by 6position: contributordoi
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study
The Lancet Oncology 2021cited by 136position: middledoi
Time-Dependent COVID-19 Mortality in Patients With Cancer
JAMA Oncology 2021cited by 72position: middledoi
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study
European Journal of Cancer 2021cited by 51position: middledoi
Predictors of intubation in COVID-19 patients treated with out-of-ICU continuous positive airway pressure
Pulmonology 2021cited by 50position: middledoi
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score
Journal for ImmunoTherapy of Cancer 2021cited by 41position: middledoi
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19.
2021cited by 19position: contributordoi
Determinants of enhanced vulnerability to COVID-19 in UK cancer patients: a European Study
UCL Discovery (University College London) 2021cited by 0position: middle
Outcomes of COVID-19 patients treated with continuous positive airway pressure outside the intensive care unit
ERJ Open Research 2020cited by 87position: middledoi
A standardized flow cytometry network study for the assessment of circulating endothelial cell physiological ranges
Scientific Reports 2018cited by 56position: middledoi
Alcohol consumption and site-specific cancer risk: a comprehensive dose–response meta-analysis
British Journal of Cancer 2014cited by 1,296position: middledoi
Alcohol drinking and cutaneous melanoma risk: a systematic review and dose-risk meta-analysis
British Journal of Dermatology 2014cited by 65position: middledoi
Drug-Induced Acute Myocardial Infarction: Identifying ‘Prime Suspects’ from Electronic Healthcare Records-Based Surveillance System
PLoS ONE 2013cited by 48position: middledoi
Light alcohol drinking and cancer: a meta-analysis
Annals of Oncology 2012cited by 403position: middledoi
Using Electronic Health Care Records for Drug Safety Signal Detection
Medical Care 2012cited by 86position: middledoi
Alcohol drinking and risk of renal cell carcinoma: results of a meta-analysis
Annals of Oncology 2012cited by 86position: middledoi
Alcohol drinking and non-Hodgkin lymphoma risk: a systematic review and a meta-analysis
Annals of Oncology 2012cited by 65position: middledoi
Alcohol drinking and epithelial ovarian cancer risk. A systematic review and meta-analysis
Gynecologic Oncology 2012cited by 55position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Rino Bellocco · Karolinska Institutet6 papers (2012–2014)Giovanni Corrao · Directorate of Health6 papers (2012–2014)Vincenzo Bagnardi · University Hospital Frankfurt6 papers (2012–2014) · 6 papers (2012–2014)Matteo Rota · University of Verona6 papers (2012–2014)Carlo La Vecchia · Centre for Sight6 papers (2012–2014)Paolo Boffetta · Community Cancer Center5 papers (2012–2014)Irene Tramacere · Neurological Surgery5 papers (2012–2014)Farhad Islami · American Cancer Society5 papers (2012–2014) · 5 papers (2012–2014)Eva Negri · Hospital Regional de Presidente Prudente5 papers (2012–2014) · 4 papers (2022–2026)Valentina Azzollini · National Institute of Neurological Disorders and Stroke2 papers (2023–2024)Johan van der Lei · Qinghai University2 papers (2012–2013)Edoardo Botteri · Norwegian Institute of Public Health2 papers (2012–2014) · 2 papers (2023–2024) · 2 papers (2023–2024)Gino Picelli · University of Padua2 papers (2012–2013)Veronika Fedirko · The University of Texas MD Anderson Cancer Center2 papers (2012–2014) · 2 papers (2023–2024)